Table 3.
M-PCR assay performance in 45 initial samples analyzed from women with BV diagnosis by Nugent criteria.
| BV-AAs detected | n | % |
|---|---|---|
| Only one BV-AA | 20 | 44.5 |
| Megasphaera type I | 9 | 45.0 |
| Mobiluncus curtisii | 6 | 30.0 |
| Gardnerella vaginalis | 4 | 20.0 |
| Mycoplasma hominis | 1 | 5.0 |
| 2 simultaneous BV-AAs | 10 | 22.2 |
| Ureaplasma urealyticum + Gardnerella vaginalis | 2 | 20.0 |
| Megasphaera type I + BVAB 1 | 2 | 20.0 |
| Mobiluncus curtisii + BVAB 1 | 1 | 10.0 |
| Megasphaera type I + M. hominis | 1 | 10.0 |
| Megasphaera type I + Atopobium vaginae | 1 | 10.0 |
| Mycoplasma hominis + Sneathia sanguinegens | 1 | 10.0 |
| Gardnerella vaginalis + BVAB 3 | 1 | 10.0 |
| Mobiluncus curtisii + BVAB 2 | 1 | 10.0 |
| 3 simultaneous BV-AAs | 6 | 13.3 |
| Megasphaera type I + BVAB 1 + BVAB 3 | 2 | 33.3 |
| Gardnerella vaginalis + BVAB 2 + BVAB 3 | 1 | 16.6 |
| Mobiluncus curtisii + BVAB 1 + BVAB 3 | 1 | 16.6 |
| Megasphaera type I + BVAB 2 + BVAB 3 | 1 | 16.6 |
| Gardnerella vaginalis + Atopobium vaginae + BVAB 2 | 1 | 16.6 |
| 4 simultaneous BV-AAs | 6 | 13.3 |
| Megasphaera type I + Atopobium vaginae + BVAB 2 + Sneathia sanguinegens | 1 | 16.6 |
| Gardnerella vaginalis + Mobiluncus curtisii + BVAB 2 + Sneathia sanguinegens | 1 | 16.6 |
| Gardnerella vaginalis + Mobiluncus curtisii + BVAB 2 + Atopobium vaginae | 1 | 16.6 |
| Gardnerella vaginalis + Atopobium vaginae + BVAB 2 + BVAB 3 | 1 | 16.6 |
| Megasphaera type I + Atopobium vaginae + BVAB 2 + BVAB 3 | 1 | 16.6 |
| Megasphaera type I + BVAB 3 + Mobiluncus mulieris + Sneathia sanguinegens | 1 | 16.6 |
| 5 simultaneous BV-AAs | 2 | 4.4 |
| Ureaplasma urealyticum + Gardnerella vaginalis + Atopobium vaginae + BVAB 1 + BVAB 2 | 1 | 50.0 |
| Mobiluncus curtisii + Megasphaera type I + BVAB 3 + Mobiluncus mulieris + Sneathia sanguinegens | 1 | 50.0 |
| 6 simultaneous BV-AAs | 1 | 2.2 |
| Gardnerella vaginalis + Mobiluncus curtisii + Megasphaera type I + Atopobium vaginae + BVAB 2 + Mobiluncus mulieris | 1 | 100.0 |
M-PCR: multiplex polymerase chain reaction; BV: bacterial vaginosis; BV-AAs: bacterial vaginosis-associated agents; BVABs 1, 2, and 3, bacterial vaginosis-associated bacteria 1, 2, and 3.